Sleep apnea-hypopnea syndrome refers to a variety of causes repeated sleep apnea and (or) low ventilation, hypercapnia, sleep disruption, leading to the bod a series of pathophysiological change to the body.
Definitions and classifications:
(A) Definition: sleep apnea-hypopnea syndrome refers to the night during sleep apnea episodes repeated 30 times or more, or sleep apnea-hypopnea index (AHI) “= 5 times / hour and was accompanied by lethargy and other clinical symptoms. Sleep apnea refers to the complete cessation of airflow in the nose and mouth breathing for more than 10 seconds; hypopnea refers to the respiratory airflow during sleep intensity (amplitude) was higher than the basic level decreased by 50% or more, accompanied by a more basic level of oxygen saturation down “ = 4% or micro-awareness; Sleep apnea-hypopnea index is within an hour of sleep apnea-hypopnea frequency.
B) Classification: 1, central type (CSAS) 2, obstructive (OSAS) 3, mixed type (MSAS)
Epidemiology:
With OSAHS, for example, in the population over 40 years, the U.S. prevalence rate of 2% -4%, more men than women, the elderly a higher prevalence in Australia of up to 6.5%.
Etiology and pathogenesis:
- (A) central-type sleep apnea syndrome (CSAS)
CSAS pure rare, generally no more than 10% of patients with apnea, also have reported that only 4%. Patency can be further divided into high and normal hypercapnia hypercapnia two major categories. CSAS can co-exist with obstructive sleep apnea hypopnea syndrome, and common accompanied with nervous system or motor system lesions.
Pathogenesis may be related to the following factors:
1.sleep respiratory center response to a variety of different stimuli decreased.
2. the instability of respiratory feedback regulation of the central nervous system to hypoxia, especialy those caused by changes in CO2 concentration.
3. exhale and inhale conversion mechanism disorders.
- obstructive sleep apnea-hypopnea syndrome (OSAHS)
Accounted for the majority of SAHS, a family gathering and genetic factors, most with upper respiratory tract, especially the nose, pharynx narrow part of the pathological basis, such as obesity, allergic rhinitis, nasal polyp, tonsil hypertrophy, soft palate relax, the palate is too long vertical too thick, tongue hypertrophy, tongue base after the fall, mandibular retrusion, temporomandibular joint dysfunction and small jaw deformities. Some endocrine diseases can also be combined with this disease. Its pathogenesis may be related to sleep state, the upper airway soft tissue, muscle collapse of increased upper airway muscles during sleep, hypoxia and carbon dioxide decreased the stimulus-response, in addition, but also nervous, humoral and endocrine factors such as the comprehensive effects.
Clinical manifestations
(A) the day time of clinical performance:
- lethargy: The most common symptoms, the performance of light who work or study time during the day and sleepiness, lethargy, severe eating, talking with people you can go to sleep, or even serious consequences, such as dozing off while driving cause traffic accidents .
- Dizziness and weakness: As the night repeated apnea, hypoxemia, so that the continuity of sleep disruption, increased frequency of awakening, sleep quality, decrease, often slightly different from the dizziness, fatigue, weakness.
- Spirit Abnormal behavior: can not concentrate, fine drop operation ability, memory and judgment decline symptoms in severe cases can not do the work, the elderly can be expressed as dementia. Nocturnal hypoxemia on the brain damage and changes in sleep architecture, especially the deep sleep phase reduction is the main reason.
- Headache: usually occurs early in the morning or at night, pain more common, non-violent, sustainable 1-2 hours, and sometimes required to the pain medication in order to ease the pain.
- Personality changes: irritable, easily agitated, anxiety, family and social life are subject to a certain extent, due to gradually alienation with family members and friends , depression may occur.
- Sexual dysfunction: About 10% of patients, there may be loss of libido and even impotence.
(B) the night of clinical performance:
- snoring: is the main symptom, snoring irregular, high and low ranges, often snoring – flow stops – breathing – snoring interspersed with the general flow interruption time for 20-30 seconds, the individual up to 2 minutes more, this time in patients with may appear obvious cyanosis.
- Apnea: 75% of the same room or bed with sleep apnea have found that patients often worry about breathing can not be restored while the push awake patients with apnea breathe more, choke, or loud snoring waking terminated. OSAHS patients have significant paradoxical thoracoabdominal
- Hold in Peter: respiratory choke suddenly wake up after a pause, often accompanied with emancipated, involuntary movements of limbs and even convulsions, or suddenly start feeling flustered, chest tightness or precordial discomfort.
- Hyperactivity anxiety: a result of hypoxemia, the patient stand up at night, turning more frequently.
- Hyperhidrosis: Sweating more, to the neck, upper chest clear and airway obstruction and apnea after forced breathing caused by the hypercapnia.
- Nocturia: Some patients with increased frequency of urination at night v. individual appears enuresis.
- Sleep Abnormal behavior: the performance of the fear, screaming, nonsense, night, hearing voices.
(C) the performance of systemic organ damage:
OSAHS patients with different cardiovascular system usually manifested often the first symptom and signs, which can be high blood pressure, coronary heart disease an independent risk factor.
- Hypertension: OSAHS patients with hypertension incidence rate of 45%, and poor therapeutic effect of antihypertensive drugs.
- Coronary heart disease: the performance for various types of arrhythmia, angina and myocardial infarction at night. The 20 coronary artery endothelial injury caused by lack of oxygen, lipid deposition in the intima, as well as an increase in red blood cells due to the increase of blood viscosity.
- Various types of arrhythmia.
- Pulmonary heart disease and respiratory failure
- Ischemic or hemorrhagic cerebrovascular disease
- Mental disorder: such as psychosis or manic depression
Laboratory and other test:
- Blood tests: long illness, severe hypoxemia, blood red blood cell count and hemoglobin may have different extents of growth.
- Arterial blood gas analysis: a serious illness or combined pulmonary heart disease, respiratory failure who may have hypoxemia, hypercapnia and respiratory acidosis.
- Chest X-ray examination: concurrent pulmonary hypertension, high blood pressure, coronary heart disease, it can shadow determined to increase the corresponding salient symptoms of pulmonary arterial segment.
- Pulmonary function tests: a serious condition with pulmonary heart disease, respiratory failure, there are different degrees of ventilation dysfunction.
- ECG: high blood pressure, coronary heart disease occurs when ventricular hypertrophy, myocardial ischemia or arrhythmia and other changes.
Diagnosis
According to the typical clinical symptoms and signs, diagnosis, SAHS is not difficult, diagnosis and understand the severity and type of illness, you need to conduct the appropriate examination.
- Clinical diagnosis: according to the patients with sleep apnea snoring, daytime sleepiness, obesity, neck circumference and other clinical symptoms of rough preliminary clinical diagnosis can be made.
- Polysomnography: PSG monitoring is the gold standard for diagnosis SAHS, and can determine the type and severity.
- Etiological diagnosis: The diagnosis of SAHS routinely ENT and oral examination, to understand whether the local anatomy and developmental abnormalities, hyperplasia and tumors. Skull and neck X-ray photographs, CT and MRI cross-sectional area measured oropharynx and can be used to determine the positioning of the narrow. Some patients with the endocrine system can be determined.
Differential Diagnosis
- Simple snoring: There are significant snoring, PSG examination does not meet the upper airway resistance syndrome, non-apnea-hypopnea without hypoxemia.
- Upper airway resistance syndrome: airway resistance increased.
- Narcolepsy: excessive daytime sleepiness, cataplexy attack.Family history.
Treatment
(A) central sleep apnea syndrome treatment
- Treatment of primary disease: If the nervous system disease, congestive heart failure treatment.
- Respiratory stimulant drugs: The main respiratory center to increase the driving force to improve the apnea and hypoxemia. Drugs: almitrine (50mg ,2-3 times / day), acetazolamide (125-250mg ,3-4 times / min or 250mg bedtime) and theophylline (100-200mg ,2-3 times / days)
- Oxygen therapy: You can correct hypoxemia, right heart failure secondary to congestive heart patients, can reduce apnea and hypopnea frequency of pairs of neuromuscular disease may be aggravated hypercapnia, but if the merger is likely to contribute to OSAHS obstructive sleep apnea.
- Assisted ventilation therapy: severe patients, mechanical ventilation can enhance breathing on his own may make use of non-invasive positive pressure ventilation and invasive mechanical ventilation.
(B) Obstructive sleep apnea-hypopnea syndrome treatment
- General treatment: (1) weight loss: diet, drugs and surgery. (2) sleep position changes: lateral sleep, raising the bed. (3) quit smoking wine, to avoid taking sedatives.
- Drug treatment: Effects not sure. Could try acetazolamide. Modafinil to improve the role of daytime sleepiness, drowsiness applied to receive CPAP treatment in patients with symptom improvement was not obvious, there are some success.
- Surgical treatment: (1) Nose surgery (2) vertical palatal palatal pharyngeal angioplasty (3) Laser-assisted UPPP (4) low-temperature radiofrequency ablation (5), orthognathic surgery